Spruce Biosciences Financial Overview
Spruce Biosciences's market cap is currently $84.28M. The company's EPS TTM is $-14.58; its P/E ratio is -0.98; Spruce Biosciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
